Evidence map›Paper›PMID 41553357›Full record

ArticleGigaScience2026

Generalizable machine learning models for rapid antimicrobial resistance prediction in unseen health care settings.

Diane Duroux, Paul P Meyer, Giovanni Visonà, Niko Beerenwinkel

Abstract read
In one paragraph

Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Diane DurouxETH AI Center, ETH Zurich, Andreasstrasse 5, 8092, Zurich, Switzerland.ORCID 0000-0002-8564-3157
Paul P MeyerDepartment of Mechanical and Process Engineering, ETH Zurich, Tannenstrasse 3, 8092, Zurich, Switzerland.
Giovanni VisonàDepartment of Empirical Inference, Max Planck Institute for Intelligent Systems, Max-Planck-Ring 4, 72076, Tübingen, Germany.
Niko BeerenwinkelDepartment of Biosystems Science and Engineering, ETH Zurich, Klingelbergstrasse 48, 4056, Basel, Switzerland.ORCID 0000-0002-0573-6119

Funding

ETH
6 · The paper itself

Abstract

backgroundThe deployment of machine learning in clinical settings is often hindered by the limited generalizability of the models. Models that perform well during development tend to underperform in new environments, limiting their clinical utility. This issue affects models designed for the rapid identification of antimicrobial resistance, which is essential to guide treatment decisions. Traditional susceptibility tests can take up to 3 days, whereas integrating matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry with machine learning has the potential to reduce this to 1 day. However, model performance declines drastically in hospitals or time frames outside the training data.

resultsTo improve robustness, we develop advanced feature representations using masked autoencoders (MAEs) for MALDI-TOF spectra and chemical language models and SELF-referencing embedded strings (SELFIES) for antimicrobials. Cross-validated on data from 4 medical institutions, our models demonstrate improved performance and stability. The MAE and SELFIES encodings increase the area under the precision-recall curve by 4% when evaluated on unseen time periods, while the MAE and Molformer language model encodings improve it by 10% when applied across different hospitals.

conclusionsThese results underscore the value of combining deep learning with chemical and spectral information to build generalizable, high-impact clinical artificial intelligence.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialMachine LearningAutoencoderHumansMicrobial Sensitivity TestsPredictive Learning ModelsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAnti-Bacterial Agentsantimicrobial resistancegeneralizabilitymachine learningrepresentation learning

Identifiers

PMID41553357
PMCPMC12908719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.